Pediarix
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Pediarix, covering 2014-01-13 to 2019-10-31. Get the full timeline:
Most recent: Clinical Trial Update: This Study Will Evaluate the Immunogenicity, Reactogenicity and Safety of the Routine Infant Vaccines Pediarix®, Hiberix® and Prevenar 13® When Co-administered With GlaxoSmithKline (GSK) Biologicals' Liquid Human Rotavirus Vaccine (HRV) as Compared to GSK's Licensed Lyophilized Vaccine [Phase 3]